Tranexemic acid for bloodless root canal
Phase 2
- Conditions
- Health Condition 1: null- Patients requiring root canal therapy in posterior teeth
- Registration Number
- CTRI/2018/01/011557
- Lead Sponsor
- Dr Roshni
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Healthy adult patients
2. Maxillary and mandibular molars
3. Vital teeth indicated for root canal for endodontic, periodontal and prosthodontal reasons
4. Moderate to severe bleeding from the pulp chamber either from a normal/ hyperemic pulp on initiating access cavity preparation
Exclusion Criteria
1. Patients on anticoagulants
2. Active intravascular clotting
3. Subarachnoid hemorrhage
4. Hypersensitivity to Tranexamic acid
5. Pregnancy of lactating mothers
6. Upper renal tract bleeding
7. Hemorrhagic diathesis
8. Occular conditions like defective color vision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Most effective method of application of Tranexamic acid to control pulpal bleeding during access cavity preparationTimepoint: 2-5 minutes
- Secondary Outcome Measures
Name Time Method To assess the effect of intrapulpal Tranexamic acid on bleeding and clotting time of the patientTimepoint: 30 minutes;To check for bleeding on re-instrumentation and need for re- application of Tranexamic acidTimepoint: 2-5 minutes;To check volume of pulpal bleeding by gravitimetric methodTimepoint: 2-5 minutes